Opportunity ID: 342686

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-22-019
Funding Opportunity Title: Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 22, 2022
Last Updated Date: Jul 22, 2022
Original Closing Date for Applications: Nov 17, 2022
Current Closing Date for Applications: Nov 17, 2022
Archive Date: Dec 23, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Special district governments
Private institutions of higher education
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Small businesses
Native American tribal governments (Federally recognized)
State governments
County governments
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 1 diabetes research (SEIC-T1D). A primary goal of the SEIC-T1D is to accelerate equitable engagement of diverse stakeholders in T1D research, particularly those from diverse communities that experience diabetes-related health disparities, as well as the healthcare and social systems that impact community members and patients health. The SEIC-T1D will provide highly specialized research resources to support investigators by fully embedding communities, people living with T1D, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T1D will also establish a network consisting of diverse, multidisciplinary research investigators with expertise in T1D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T1D early detection and treatment.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-22-019.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or after January 25, 2022 PKG00276141 Oct 17, 2022 Nov 17, 2022 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277514 Oct 27, 2022 Nov 17, 2022 View

Package 1

Mandatory forms

342686 RR_SF424_5_0-5.0.pdf

342686 PHS398_CoverPageSupplement_5_0-5.0.pdf

342686 RR_OtherProjectInfo_1_4-1.4.pdf

342686 PerformanceSite_4_0-4.0.pdf

342686 RR_KeyPersonExpanded_4_0-4.0.pdf

342686 PHS398_ResearchPlan_4_0-4.0.pdf

342686 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

342686 PHS_Additional_IndirectCosts_2_0-2.0.pdf

342686 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

342686 RR_SF424_5_0-5.0.pdf

342686 PHS398_CoverPageSupplement_5_0-5.0.pdf

342686 RR_OtherProjectInfo_1_4-1.4.pdf

342686 PerformanceSite_4_0-4.0.pdf

342686 RR_KeyPersonExpanded_4_0-4.0.pdf

342686 PHS398_ResearchPlan_5_0-5.0.pdf

342686 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

342686 PHS_Additional_IndirectCosts_2_0-2.0.pdf

342686 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T12:59:16-05:00

Share This Post, Choose Your Platform!

About the Author: